Merck
Merck says deal signed with Singapore on COVID-19 antiviral pill
Merck announced on Wednesday a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID-19 antiviral drug,…
Merck’s COVID-19 pill cuts risk of death, hospitalization by 50% in study
Merck & Co Inc's experimental oral drug for COVID-19, molnupiravir, reduced by around 50% the chance of hospitalization or death for patients…
Merck says research shows its COVID-19 pill works against variants
Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of…
Supply fears lead EU vaccine industry to seek home comforts
European companies playing key supporting roles in COVID-19 vaccine manufacturing are working to move production and supply chains closer to their customers…
Merck says study shows COVID-19 drug causes quick reduction in virus
U.S. drugmaker Merck & Co Inc said the experimental antiviral drug molnupiravir it is developing with Ridgeback Bio showed a quicker reduction…
France’s Institut Pasteur stopping one of its potential COVID-19 vaccine projects
France's Pasteur Institute said that it was terminating the development of a Covid-19 vaccine with US pharmaceutical company Merck after clinical trial…
Merck starts recruitment for COVID-19 vaccine trial
U.S. drug maker Merck & Co Inc has begun recruiting participants to its early-stage COVID-19 vaccine study, according to the government database…